| scholarly article | Q13442814 |
| P2093 | author name string | Barbara E Corkey | |
| Karel Erion | |||
| P2860 | cites work | Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction | Q21246041 |
| Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence | Q27027739 | ||
| Mechanisms of fatty acid-induced inhibition of glucose uptake | Q28369732 | ||
| Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review | Q28385151 | ||
| Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3 | Q28609897 | ||
| Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance | Q30434586 | ||
| Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study. | Q33843643 | ||
| Childhood size and life course weight characteristics in association with the risk of incident type 2 diabetes | Q33873200 | ||
| What Are We Putting in Our Food That Is Making Us Fat? Food Additives, Contaminants, and Other Putative Contributors to Obesity | Q33914328 | ||
| Endocrine disruptors in the etiology of type 2 diabetes mellitus. | Q34176083 | ||
| Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways | Q34245582 | ||
| Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study | Q34262967 | ||
| Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability | Q34505731 | ||
| Both fasting and glucose-stimulated proinsulin levels predict hyperglycemia and incident type 2 diabetes: a population-based study of 9,396 Finnish men | Q35325334 | ||
| Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus | Q35552583 | ||
| Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes | Q35762624 | ||
| Chronic Exposure to Excess Nutrients Left-shifts the Concentration Dependence of Glucose-stimulated Insulin Secretion in Pancreatic β-Cells | Q35783124 | ||
| Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects | Q35809532 | ||
| Inhibition of Monoacylglycerol Lipase Activity Decreases Glucose-Stimulated Insulin Secretion in INS-1 (832/13) Cells and Rat Islets | Q35920878 | ||
| Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism | Q36411159 | ||
| Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? | Q36411656 | ||
| Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes? | Q36426723 | ||
| Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review | Q36602285 | ||
| Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial | Q36784428 | ||
| Adolescent BMI trajectory and risk of diabetes versus coronary disease | Q37080874 | ||
| Metabolic syndrome, hyperinsulinemia, and cancer | Q37081280 | ||
| Bimodal distribution of glucose is not universally useful for diagnosing diabetes | Q37105153 | ||
| Antidiabetic action of bezafibrate in a large observational database | Q37139567 | ||
| Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. | Q37304741 | ||
| Disproportionately Elevated Proinsulin Levels as an Early Indicator of β-Cell Dysfunction in Nondiabetic Offspring of Chinese Diabetic Patients. | Q37322694 | ||
| Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. | Q37428285 | ||
| Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog. | Q37672590 | ||
| Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think | Q38223003 | ||
| Hyperinsulinemia: a Cause of Obesity? | Q39280021 | ||
| Improvement in insulin secretion in diabetes after diazoxide | Q39368203 | ||
| Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates | Q39502998 | ||
| Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood | Q40369831 | ||
| A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. | Q40734688 | ||
| Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats | Q41182816 | ||
| Insulin and BMI as predictors of adult type 2 diabetes mellitus | Q41656099 | ||
| Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. | Q41756772 | ||
| Diabetes and its drivers: the largest epidemic in human history? | Q42338492 | ||
| NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat | Q42450731 | ||
| Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells | Q42490936 | ||
| The possible mechanisms by which phanoside stimulates insulin secretion from rat islets | Q42507924 | ||
| Antiobesity effect of diazoxide in obese Zucker rats | Q42516151 | ||
| Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats. | Q42804860 | ||
| Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose | Q44757149 | ||
| Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats | Q44815328 | ||
| Openers of ATP-dependent K+-channels protect against a signal-transduction-linked and not freely reversible defect of insulin secretion in a rat islet transplantation model of Type 2 diabetes | Q44847063 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus | Q46161786 | ||
| The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener, in healthy male subjects | Q46542206 | ||
| Very slow turnover of beta-cells in aged adult mice | Q46670100 | ||
| Weight and Metabolic Outcomes 12 Years after Gastric Bypass | Q47186948 | ||
| Increasing body mass index z-score is continuously associated with complications of overweight in children, even in the healthy weight range | Q47313868 | ||
| Intraventricular insulin and the level of maintained body weight in rats | Q47352883 | ||
| Effect of chronic insulin administration on food intake and body weight in rats | Q47424600 | ||
| Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults | Q48136074 | ||
| A 2-year Trial of Intermittent Insulin Therapy versus Metformin for the Preservation of Beta-cell Function after Initial Short-term Intensive Insulin Induction in early Type 2 Diabetes. | Q48151386 | ||
| Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass. | Q50079410 | ||
| Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. | Q50520401 | ||
| Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients. | Q51318977 | ||
| Decreased number of insulin receptors in obesity: studies in the obese hyperglycemic mouse (author's transl) | Q51671363 | ||
| Childhood adiposity, adult adiposity, and cardiovascular risk factors. | Q53141828 | ||
| Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. | Q54194095 | ||
| Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer | Q67442152 | ||
| Concomitant food intake and adipose tissue responses under chronic insulin infusion in rats | Q70255794 | ||
| Kinetics of proinsulin conversion in human islets | Q70721752 | ||
| Effects of a 48-h fat infusion on insulin secretion and glucose utilization | Q71736931 | ||
| Beneficial effect of diazoxide in obese hyperinsulinemic adults | Q74645788 | ||
| Acute lowering of plasma fatty acids lowers basal insulin secretion in diabetic and nondiabetic subjects | Q77349175 | ||
| Long-term effect of bezafibrate on pancreatic beta-cell function and insulin resistance in patients with diabetes | Q80257227 | ||
| The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener in subjects with type 2 diabetes | Q80802150 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 532 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | β-Cell Failure or β-Cell Abuse? | |
| P478 | volume | 9 |
Search more.